Summit Clinical Research

Today, we announced that our MAESTRO-NASH OUTCOMES trial evaluating a potential treatment for patients with compensated #NASH / #MASH cirrhosis has completed enrollment. Read the full announcement: https://bit.ly/3Yb8tDL

#SummitClinicalResearch is attending #ObesityWeek, Nov. 3-6, in our beautiful hometown of San Antonio, Texas! 🎉 Visit us at booth #416 to learn more about our expansion into obesity clinical trials, a new therapeutic area for us. We’re eager to collaborate with industry leaders and partners to make an impact in this critical field. #OW2024 #ObesityResearch #ClinicalTrials The Obesity Society ObesityWeek®

⚠️This EASL DeepDive is happening in less than a week! ⚠️ Register to learn about the role of glucagon and glucagon-receptors in physiology & in #MASH patients. 🔗https://lnkd.in/dEj4GGrm ✨Attend the live event to earn 1-CME! ✨

AASLD is pleased to announce our latest update for our 2023 Practice Guidance on the Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). View the latest update online now! https://lnkd.in/euxRkSUE #AASLD #AASLDNews #MASLD #MASH

Congratulations to Jesse Coppage, our Recruitment & Retention Manager, on his 4th #anniversary with #SummitClinicalResearch! #TeamSummit #ClinicalResearch

Congratulations to Helen Cary, our Document Management Specialist, on her 3rd #anniversary with #SummitClinicalResearch! #TeamSummit #ClinicalResearch

Exciting Announcement from Arizona Liver Health Our Chief Medical Officer, Dr. Naim Alkhouri, is excited to share groundbreaking news about advancements in diagnosing at-risk MASH for our patients. “I’m pleased to announce the availability of a new blood-based test for patients with suspected fatty liver disease. This new test, called OWLiver, helps determine the severity of liver disease by measuring metabolites, specifically lipid species, in the blood.” - Dr. Alkhouri. The test, conducted in a fasting state, provides three potential outcomes: simple fatty liver disease, metabolic dysfunction-associated steatohepatitis (MASH), or at-risk MASH, which indicates steatohepatitis along with moderate to advanced fibrosis. Diagnosing fatty liver disease is vital for our patients' care, and we’re proud to offer this advanced diagnostic tool to better serve their health needs. If you are a physician interested in referring a patient, please click the link below: https://lnkd.in/gmzASu_z OWL Metabolomics Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Tessa Janovsky Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Aileen Tammany Chelsea Ann Mihaylo Hum, PMP Mazen Noureddin, MD, MHSc Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Summit Clinical Research, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Fatty Liver Alliance

🎃 Monster MASH Mondays are here! 🎃 Every Monday in October, join us LIVE as Dr. Naim Alkhouri, MD, FAASLD, and Dr. Jay Shubrook, DO, break down everything you need to know about MASH—Metabolic dysfunction-associated Steatohepatitis. From diagnosis to treatment, and even patient perspectives, they'll cover it all in just 15 minutes! Starting today, October 7th at 8:00 PM, don’t miss your opportunity to dive into this often overlooked chronic liver disease. 👉 Tune in here: http://ms.spr.ly/6042meOBr #MASHMondays #LiverHealth #ChronicDisease #HealthcareEducation #MASHAwareness Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Angie Coste Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Medscape Jay Shubrook Amreen Dinani Tony Villiotti Mazen Noureddin, MD, MHSc Michelle Jones Kelly Black Nick Engelke Ashwani Singal Madrigal Pharmaceuticals Echosens

Register today for our Third Annual MASLD and MASH Primary Care Summit, December 5, 2024. Today we are highlighting Mazen Noureddin, MD, MHSc, Professor of Medicine, Transplant Hepatologist Houston Methodist who will be sharing the very latest on the "understanding and diagnosing of MASLD and MASH: What PCPs need to know". Link to register: https://lnkd.in/eHGDEvpY American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Global NASH Council, Canadian Association for the Study of the Liver, Houston Liver Institute, Naim Alkhouri, MD, FAASLD, MCI, Supriya Joshi, Mark Donnison, MBA, Philippe Garneau, Hsiao-Ming Jung, James Kim, Global Liver Institute, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, Summit Clinical Research, Arizona Liver Health, Prof. Shira Zelber Sagi, Giada Sebastiani, Sahar Saeed

Happy 3 Year #WorkAnniversary to Chris Malavolta! #TeamSummit #ClinicalResearch